[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Starling Oncology Institute Inc (STLN)

Starling Oncology Institute Inc (STLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Starling Oncology Institute Inc 18000 STUDEBAKER ROAD SUITE 800 CERRITOS CA 90703 USA

www.starlingoncology.com Employees: 641 P: 562-735-3226

Sector:

Medical

Description:

Starling Oncology Inc. is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. Starling Oncology Inc., formerly known as The Oncology Institute Inc., is based in CERRITOS, Calif.

Key Statistics

Overview:

Market Capitalization, $K 622,686
Enterprise Value, $K 666,516
Shares Outstanding, K 98,839
Float, K 94,490
% Float 95.60%
Short Volume Ratio 0.63
% of Insider Shareholders 4.40%
% of Institutional Shareholders 36.86%

Financials:

Annual Sales, $ 502,730 K
Annual Net Income, $ -60,610 K
Last Quarter Sales, $ 161,280 K
Last Quarter Net Income, $ -9,790 K
EBIT, $ -19,290 K
EBITDA, $ -3,970 K

Growth:

1-Year Return 85.67%
3-Year Return 447.83%
5-Year Return -36.43%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.08 on 08/06/26
Next Earnings Date 11/12/26
Earnings Per Share ttm -0.30
EPS Growth vs. Prev Qtr -300.00%
EPS Growth vs. Prev Year 46.67%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

STLN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -21.52%
Profit Margin % -12.06%
Debt/Equity -3.21
Price/Sales 1.21
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.25
Interest Coverage -4.38
60-Month Beta 0.38
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.